Sept 18 (Reuters) - Moderna Inc MRNA.O said on Friday it expects to produce 20 million doses of its experimental coronavirus vaccine by the end of the year.
The company continues to expect to make 500 million to 1 billion doses of the vaccine in 2021, Moderna said in a filing with the U.S. securities regulators. (https://bit.ly/35PkSnc)
(Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)
((Manas.Mishra@thomsonreuters.com; www.twitter.com/Manasmishra24; within U.S. +1 646 223 8780, outside U.S. +91 806749 2709))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.